Company: NCEL
Filing Date: 2025-06-09
Form Type: F-4/A
Source: 0001213900-25-052354
Chunk: 302

Company: NewcelX Ltd.
Filing Date: 2025-06-09
Form: F-4/A
Chunk 302
---
daq and therefore subject to the Securities Act, and as such, all relevant information is available to the Israeli public, and NLS shall continue to provide information in accordance with the Securities Act. Kadimastem’s request remains in process with the ISA. Pursuant to Kadimastem’s petition to the court, the court ordered that Kadimastem will convene a shareholders’ meeting for approval of the merger. In addition, in connection with the Merger, Kadimastem is in the process of obtaining a 103K Tax Ruling, from the tax authorities in Israel; both NLS and Kadimastem are required to comply with the provisions thereunder. Pursuant to the 103K Tax Ruling, shareholders of Kadimastem will sell their Kadimastem Ordinary Shares to NLS in exchange for NLS Common Shares, without the exchange being considered a tax event. The request for ruling has been submitted to the Israeli Tax Authority and is pending approval. Kadimastem shareholders have approved the following matters in connection with the Merger: 1.Approval of the Merger Agreement; 2.Approval of Kadimastemdelisting from trading on the Tel Aviv Stock Exchange Ltd. upon completion of the Merger. 3.Approval of the subsequent listing of NLS on the Nasdaq in connection with the Merger; 4.Approval of the eventual change of name and symbol of NLS on Nasdaq following the Merger; 5.Approval of the participation in the purchase of a Run Off insurance policy of up to $200,000 for the officers and directors of NLS that are stepping down as directors and officers of NLS as part of the Merger; 6.Approval of the purchase of directors and officers insurance for the combined company; 7.Approval of the entering into a CVR Agreement as part of the Merger; 8.Approval of the conversion of options and RSUs into equivalent securities with identical rights in NLSP at the Closing; 9.Approval of an amendment of the Kadimastem’s Articles of Association; 10.Appointment of directors in the combined company to replace the current directors of NLS, who will conclude their terms upon completion of the Merger, in accordance with the provisions of the Merger Agreement, and approval of the terms of office for the new directors; 11.Appointment and approval of the terms of office for Mr. Ronen Twito as CEO